People with HIV can now receive a potentially life-saving kidney or liver from a donor who is also infected with the virus, according to new rules announced Tuesday by the Biden administration. According to an announcement from...

The outgoing Biden administration will propose that pricey GLP-1 obesity medications such as semaglutide (Wegovy), and tirzepatide (Zepbound) be covered by Medicare and Medicaid. However, the move would have to be approved by the new Trump administration. ...

It’s common to find a pitcher soaking their elbow in an ice bucket following a baseball game, in an effort to save their arm for tomorrow’s innings. But athletes about to hit the turf would be better...

TUESDAY, Nov. 26, 2024 (HeathDay News) — A potentially important form of brain signaling appears to be affected whenever concussion strikes, according to new research involving high school football players. “This study is important because it provides...

The potential health benefits of GLP-1 diabetes and weight loss meds keep piling up: New research shows they may also shield your kidneys from harm. In the largest study to date on the effects of the drugs...

The “brain fog” of long COVID might be due to impaired lung function following a person’s infection, a new small-scale study says. Reduced gas exchange in the lungs – oxygen coming in, carbon dioxide going out —...

A gene that causes accelerated reproductive aging is directly tied to the risk of miscarriage in younger women, a new study says. A mutation of the gene KIF18A speeds up the aging process of eggs in younger...

Preschoolers prone to tantrums appear to have a higher risk of attention-deficit/hyperactivity disorder (ADHD) by the time they reach school age, a new study says. Young children who struggle to control their emotions and behavior have more...

Moms who eat right during pregnancy are setting their kids up for good health, a new study says. Expectant mothers who ate a quality diet were more likely to have kids with healthy birth weights, steadier growth...

Cisplatin is the go-to chemotherapy for people battling head-and-neck cancers, but nearly a third of patients can’t tolerate its side effects and quit the drug. A new trial offers surprising results on the best second-line drug to...